Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09VQZ
|
||||
Former ID |
DNC011108
|
||||
Drug Name |
4-((3',4'-Difluorobiphenyl-4-yl)methyl)pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531085] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H13F2N
|
||||
Canonical SMILES |
C1=CC(=CC=C1CC2=CC=NC=C2)C3=CC(=C(C=C3)F)F
|
||||
InChI |
1S/C18H13F2N/c19-17-6-5-16(12-18(17)20)15-3-1-13(2-4-15)11-14-7-9-21-10-8-14/h1-10,12H,11H2
|
||||
InChIKey |
KREPMUWCVWQPGH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [531085] | |
17 alpha-hydroxylase-C17, 20-lyase | Target Info | Inhibitor | [531085] | ||
PathWhiz Pathway | SteroidogenesisPW000045:Androgen and Estrogen Metabolism | ||||
Steroidogenesis | |||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormoneWP702:Metapathway biotransformation | |||||
Steroid Biosynthesis | |||||
Glucocorticoid & Mineralcorticoid Metabolism | |||||
Prostate Cancer | |||||
Phase 1 - Functionalization of compounds | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.